Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Annals of the Rheumatic Diseases|February 1, 2015
Evidence-based provisional clinical classification criteria for autoinflammatory periodic feversSilvia Federici, Maria Pia Sormani, Seza Ozen, et al.
Annals of the Rheumatic Diseases|June 13, 2012
Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative studyJoachim Gerss, Johannes Roth, Dirk Holzinger, et al.
The Journal of Rheumatology|August 1, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
The Journal of Rheumatology|August 5, 2025
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
The New England Journal of Medicine|December 21, 2012
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritisNicolino Ruperto, Hermine I Brunner, Pierre Quartier, et al.
Annals of the Rheumatic Diseases|April 13, 2018
Treating juvenile idiopathic arthritis to target: recommendations of an international task forceAngelo Ravelli, Alessandro Consolaro, Gerd Horneff, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2014
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patientsFrancesca Minoia, Sergio Davì, AnnaCarin Horne, et al.
Lancet (London, England)|November 12, 2021
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trialNicolino Ruperto, Hermine I Brunner, Olga Synoverska, et al.
Annals of the Rheumatic Diseases|February 12, 2016
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
Annals of the Rheumatic Diseases|April 24, 2010
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteriaSeza Ozen, Angela Pistorio, Silvia M Iusan, et al.
Pageof 13